Atlas Trials

Carcinoma of Ureter

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Carcinoma of Ureter

RecordFirmDate
Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma (NCT01282463)Eli Lilly and Company2011-04-01

Track Carcinoma of Ureter automatically

Every clearance here is in the API, with alerts when new ones post.